SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039295
Filing Date
2020-08-11
Accepted
2020-08-11 16:05:59
Documents
72
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-10q_20200630.htm   iXBRL 10-Q 3369154
2 EX-10.12 vir-ex1012_223.htm EX-10.12 27972
3 EX-31.1 vir-ex311_8.htm EX-31.1 21004
4 EX-31.2 vir-ex312_6.htm EX-31.2 20893
5 EX-32.1 vir-ex321_7.htm EX-32.1 9681
  Complete submission text file 0001564590-20-039295.txt   10521092

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vir-20200630.xsd EX-101.SCH 79464
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vir-20200630_cal.xml EX-101.CAL 57037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vir-20200630_def.xml EX-101.DEF 293370
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20200630_lab.xml EX-101.LAB 569811
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20200630_pre.xml EX-101.PRE 455072
11 EXTRACTED XBRL INSTANCE DOCUMENT vir-10q_20200630_htm.xml XML 1608964
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 201092447
SIC: 2836 Biological Products, (No Diagnostic Substances)